Isosorbide mononitrate

A nitric oxide donor with cardioprotective activity

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
500mg

￥425.00

340.00

- +
1g

￥512.00

410.00

- +
5g

￥800.00

640.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

货号: ajce56934
CAS: 16051-77-7
别名: 单硝酸异山梨酯; Isosorbide-5-mononitrate
分子式: C6H9NO6
分子量: 191.14
纯度: >98%
溶解度: DMSO: ≥ 100 mg/mL (523.18 mM); Water: 50 mg/mL (261.59 mM)
储存: Store at -20°C
库存: 现货

Background

Isosorbide mononitrate (ISMN) is a nitric oxide (NO) donor with cardioprotective activity.^1,2,3 It induces relaxation of precontracted isolated rat mesenteric artery rings with and without endothelium (EC₅₀s = 87 and 30.1 ?M, respectively).¹ ISMN (150 mg/kg) prevents increases in blood pressure and plasma levels of thromboxane A₂ (TXA₂), as well as reduces platelet aggregation in a rat model of hypertension induced by cyclosporin A when administered prior to CsA.² However, ISMN exacerbates the CsA-induced cardiac phenotype in rats when administered seven weeks after initial CsA administration. ISMN (200 mg/kg) decreases aortic superoxide production, reduces intima-media thickness of the thoracic aorta, and improves endothelium-dependent vasorelaxation in a rabbit model of cholesterol-enriched diet-induced atherosclerosis.³ It also prolongs survival time of mice in a normobaric hypoxia test.⁴ Formulations containing ISMN have been used in the treatment of angina in patients with coronary artery disease.

1.Stepanovi?-Petrovi?, R.M., V., S., Tomi?, M.A., et al.Comparison of vasorelaxant effect and tolerance profile of a novel isosorbide-5-mononitrate derivative with its stereoisomer and parent drug on rat mesenteric arteryArznei-forschung60(4)189-197(2010) 2.Reis, F., Ponte, L., Teixeira-Lemos, E., et al.Curative isosorbide-5-mononitrate treatment, in opposition to the beneficial preventive one, aggravates the prothrombotic and proconstrictor state in cyclosporine-induced hypertensive ratsClin. Exp. Pharmacol. Physiol.32(8)640-648(2005) 3.Müller , S., K?nig, I., Meyer, W., et al.Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrateJ. Am. Coll. Cardiol.44(3)624-631(2004) 4.Fan, P.-C., Ma, H.-P., Jiang, W., et al.Anti-hypoxia activity of the novel NO donor acetyl ferulic isosorbide mononitrate in acute high-altitude hypoxia miceBiol. Pharm. Bull.38(9)1280-1289(2015)